Page 1 | Search Results | Blood | American Society of Hematology

1-6 of 6

Sort by

Sort Order Select

Journal Articles

IGF-IR tyrosine kinase interacts with NPM-ALK oncogene to induce survival of T-cell ALK + anaplastic large-cell lymphoma cells

Ping Shi, Raymond Lai, Quan Lin, Abid S. Iqbal, Leah C. Young, Larry W. Kwak, Richard J. Ford, Hesham M. Amin

Blood (2009) 114 (2): 360–370.

https://doi.org/10.1182/blood-2007-11-125658

Published: 2009

Includes: Supplemental data

Journal Articles

BCR-ABL1 mediates up-regulation of Fyn in chronic myelogenous leukemia

Kechen Ban, Yin Gao, Hesham M. Amin, Adrienne Howard, Claudia Miller, Quan Lin, Xiaohong Leng, Mark Munsell, Menashe Bar-Eli, Ralph B. Arlinghaus, Joya Chandra

Blood (2008) 111 (5): 2904–2908.

https://doi.org/10.1182/blood-2007-05-091769

Published: 2008

Journal Articles

Fyn Upregulation Is a Novel ROS-Dependent Mechanism Controlling CML Growth, Progression and Imatinib Resistance.

Joya Chandra, PhD, Hesham M. Amin, MD, Adrienne Howard, Claudia P. Miller, MS, Quan Lin, PhD, Kechen Ban, PhD

Blood (2006) 108 (11): 2241.

https://doi.org/10.1182/blood.V108.11.2241.2241

Published: 2006

Journal Articles

Autocrine release of interleukin-9 promotes Jak3-dependent survival of ALK + anaplastic large-cell lymphoma cells

Lin Qiu, Raymond Lai, Quan Lin, Esther Lau, David M. Thomazy, Daniel Calame, Richard J. Ford, Larry W. Kwak, Robert A. Kirken, Hesham M. Amin

Blood (2006) 108 (7): 2407–2415.

https://doi.org/10.1182/blood-2006-04-020305

Published: 2006

Journal Articles

Role of Jak3 in Chronic Myeloid Leukemia: Evidence To Identify Jak3 as a Potential Therapeutic Target.

Quan Lin, MD, MS, M. Ludmila Prudkin, MD, Hagop M. Kantarjian, MD, Jorge E. Cortes, MD, Esther Lau, Ioannis Grammatikakis, Vilmos A. Thomazy, MD, PhD, Raymond Lai, MD, PhD, Hesham M. Amin, MD, MSc

Blood (2005) 106 (11): 2870.

https://doi.org/10.1182/blood.V106.11.2870.2870

Published: 2005

Journal Articles

Inhibition of Akt increases p27 Kip1 levels and induces cell cycle arrest in anaplastic large cell lymphoma

George Z. Rassidakis, Marianna Feretzaki, Coralyn Atwell, Ioannis Grammatikakis, Quan Lin, Raymond Lai, Francois-Xavier Claret, L. Jeffrey Medeiros, Hesham M. Amin

Blood (2005) 105 (2): 827–829.

https://doi.org/10.1182/blood-2004-06-2125

Published: 2005

NARROW

IGF-IR tyrosine kinase interacts with NPM-ALK oncogene to induce survival of T-cell ALK + anaplastic large-cell lymphoma cells

BCR-ABL1 mediates up-regulation of Fyn in chronic myelogenous leukemia

Fyn Upregulation Is a Novel ROS-Dependent Mechanism Controlling CML Growth, Progression and Imatinib Resistance.

Autocrine release of interleukin-9 promotes Jak3-dependent survival of ALK + anaplastic large-cell lymphoma cells

Role of Jak3 in Chronic Myeloid Leukemia: Evidence To Identify Jak3 as a Potential Therapeutic Target.

Inhibition of Akt increases p27 Kip1 levels and induces cell cycle arrest in anaplastic large cell lymphoma

Email alerts

ASH Publications

American Society of Hematology

IGF-IR tyrosine kinase interacts with NPM-ALK oncogene to induce survival of T-cell ALK + anaplastic large-cell lymphoma cells

BCR-ABL1 mediates up-regulation of Fyn in chronic myelogenous leukemia

Fyn Upregulation Is a Novel ROS-Dependent Mechanism Controlling CML Growth, Progression and Imatinib Resistance.

Autocrine release of interleukin-9 promotes Jak3-dependent survival of ALK + anaplastic large-cell lymphoma cells

Role of Jak3 in Chronic Myeloid Leukemia: Evidence To Identify Jak3 as a Potential Therapeutic Target.

Inhibition of Akt increases p27 Kip1 levels and induces cell cycle arrest in anaplastic large cell lymphoma

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only